news news news
Skinvisible Pharmaceuticals, Inc. Set To Launch New Antibacterial Hand
Sanitizer, To Be Sold Under The Name 'Safe4Hours' Through Commercial and
Retail Outlets
LAS VEGAS, Mar 6, 2000 /PRNewswire via COMTEX/ -- Skinvisible, Inc. (OTC
Bulletin Board: SKVI) announced today that its wholly owned subsidiary,
Skinvisible Pharmaceuticals, Inc. has successfully completed clinical laboratory
tests demonstrating proven results for its newly developed antibacterial hand
sanitizer which will be marketed under the name Safe4Hours to commercial and
retail outlets.
"Our research strongly indicates that Safe4Hours outperforms anything else
available, inherently due to the unique qualities of our proprietary polymer
delivery technology," says Terry Howlett, President of Skinvisible, Inc. "We
listened to consumers and entered this marketplace to deliver a product that
addresses what users are really looking for."
Skinvisible developed its new antibacterial hand sanitizer to meet strong market
demand for a sanitizer that offers maximum protection without drying out the
skin, and endurance for prolonged periods without washing off. While most other
products on the market contain alcohol, the culprit for dry skin, and must be
reapplied after each hand washing, Safe4Hours is alcohol-free and has proven
persistent antimicrobial and antibacterial activity for up to 4 hours regardless
of repeated hand washing during that time. It kills food-borne bacteria, aids in
the prevention of cross-contamination, is moisturizing, and promotes dermal
health to resist penetration of environmental and chemical irritants. The name
Safe4Hours says it all.
Headquartered in Las Vegas, Nevada, Skinvisible Pharmaceuticals, Inc. develops,
manufactures and markets a proprietary and innovative topical delivery
technology that has broad industry applications. Consistent with its long-term
strategy, Skinvisible is currently developing strategic alliances and license
opportunities within the pharmaceutical field to maximize the commercialization
of its technology for skincare and transdermal drug applications. The Company is
also establishing private label business opportunities for its hand sanitizer in
response to identified demand within the medical, food service, and personal
consumer marketplace. |
